| Synonyms: | |
| Status: | Approved (2006) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | J05AF11 |
| UNII: | 2OC4HKD3SF |
| InChI Key | IQFYYKKMVGJFEH-CSMHCCOUSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C10H14N2O5 |
| Molecular Weight | 242.23 |
| AlogP | -1.51 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 104.55 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 17.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | DNA polymerase/reverse transcriptase inhibitor | DailyMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Structural protein
|
819 | - | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hepatitis B, Chronic | 4 | D019694 | ClinicalTrials |
| Hepatitis B, Chronic | 4 | D019694 | ClinicalTrials |
| Virus Diseases | 4 | D014777 | ClinicalTrials |
| Hepatitis | 3 | D006505 | ClinicalTrials |
| Liver Cirrhosis | 3 | D008103 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 63624 |
| ChEMBL | CHEMBL374731 |
| DrugBank | DB01265 |
| DrugCentral | 4220 |
| EPA CompTox | DTXSID30187813 |
| FDA SRS | 2OC4HKD3SF |
| Human Metabolome Database | HMDB0015394 |
| PDB | LLT |
| PharmGKB | PA164760861 |
| SureChEMBL | SCHEMBL124279 |
| ZINC | ZINC000000002159 |